Creative Bioarray, a provider of life science research reagents and services, has announced the release of a new suite of personalized, high-efficiency in vitro metabolic assay kits and reagents designed to support researchers and pharmaceutical companies in drug development. The kits aim to enable scientists to study metabolic pathways and drug efficacy with greater ease and precision, addressing the critical role of drug metabolism in early-stage drug testing.
The newly launched kits are built upon the widely used cytochrome P450 (CYP450) and UDP-glucuronyl transferase (UGT) enzyme systems, allowing researchers to gain insights into Phase I and Phase II metabolic processes. These pathways are essential for understanding compound metabolic stability, drug interactions, and identifying metabolic pathways, which are crucial for informed decision-making in drug development. According to Creative Bioarray, the kits offer comprehensive support for drug testing, enabling detailed assessments of interactions between various compounds and metabolic enzymes.
Key features of the kits include customizable protocols that allow users to tailor experiments to their specific needs, improving the relevance and reliability of the data obtained. The scalable solutions are designed to meet diverse throughput requirements, making them suitable for both small laboratories and large-scale industrial applications. Hannah Cole, the marketing director of Creative Bioarray, stated, "Our kits generate data that is not only quantitative but also robust and reproducible, significantly improving the overall efficiency of the drug discovery process. With our in vitro metabolic analysis kits, researchers can have complete confidence in the precision and accuracy of their results."
The kits focus on Phase I and II metabolic reactions, such as oxidation, reduction, hydrolysis, conjugation, and the formation of more readily excreted polar metabolites. By using these products, researchers can accelerate drug development and maintain a leading position in the competitive biopharmaceutical field. In addition to the kits, Creative Bioarray offers specialized services related to in vitro metabolism, including custom assays for drug interactions and metabolite identification, expanding its support throughout the entire drug development process.
For more information about Creative Bioarray's in vitro metabolism assay kits, visit Creative Bioarray.
